Sarah Cannon Research Institute UK

The Sarah Cannon Research Institute UK, part of the Hospital Corporation of America (HCA) network, is a specialized clinical research facility focused on the development of novel cancer therapies. With a team of 60 oncologists from Leaders in Oncology Care (LOC), they offer clinical research options for cancer patients in London and the United Kingdom. They are the first trials unit outside the NHS to offer new anti-cancer drugs in clinical trials, with a focus on fast study set-up timelines to provide rapid access to investigational drug therapies for both private and NHS patients. SCRI UK collaborates closely with clinical investigators to develop innovative cancer therapies for patients.